Trial Profile
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs LE SN38 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2009 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.